<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="12884">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02939196</url>
  </required_header>
  <id_info>
    <org_study_id>OH</org_study_id>
    <nct_id>NCT02939196</nct_id>
  </id_info>
  <brief_title>Pain in Different Office Hysteroscopy Diameter</brief_title>
  <official_title>Comparison of Pain Accompanying the Use of 3.7 mm and 4 mm Office Hysteroscopy in Nullipara: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the investigators'study was To compare 2 different diameter rigid
      hysteroscopy in vaginoscopic approach regarding pain during and after the procedure.

      And to evaluate patient acceptability and tolerability in order to determine the best way to
      perform hysteroscopy in an outpatient setting.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Office hysteroscopy is used as diagnostic tool to investigate abnormal uterine bleeding and
      other diseases involving the uterine cavity one of The main limitation to its widespread use
      is feared from pain and low patient tolerability Narrower diameter hysteroscopy and
      endometrial biopsy devices are being developed to improve the acceptability of office
      hysteroscopy. Miniature optical systems allow performance of most diagnostic and operative
      hysteroscopy (after proper patient selection) in an outpatient or office setting .Flexible
      hysteroscopy seem to be less painful at the beginning and during the procedure ,but the
      optical qualities are poor Hysteroscopy is safe, feasible and accurate procedure for
      diagnosing intrauterine pathology.

      Provision of outpatient based diagnostic and operative services are gaining prominence as a
      standard of cure but the experience of pain can be off-putting for patients having
      outpatient diagnostic hysteroscopy.

      saline solution is an excellent alternative to carbon dioxide in women undergoing outpatient
      hysteroscopy, and there are fewer complications
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>November 2016</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">May 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double Blind (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain more than 4 (according visual analogue scale</measure>
    <time_frame>5 minute</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Pain Associated Office Hysteroscopy</condition>
  <arm_group>
    <arm_group_label>Group(A)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2.7 mm rigid hysteroscopy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group(B)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2.9 mm rigid hysteroscopy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>office hysteroscopy 3.7</intervention_name>
    <description>office hysteroscopy with a 3.7 -mm outer sheath</description>
    <arm_group_label>Group(A)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>office hysteroscopy 4</intervention_name>
    <description>office hysteroscopy with a4-mm outer sheath</description>
    <arm_group_label>Group(B)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Woman with nulliparous cervix

        Exclusion Criteria:

          -  Pregnancy.

          -  female genital cancer

          -  Active pelvic infection

          -  Multipara

          -  patient not receiving misoprostol
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Essam Othman, MD</last_name>
    <email>essamrash@yahoo.com</email>
  </overall_contact>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>October 18, 2016</lastchanged_date>
  <firstreceived_date>October 18, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Essam Rashad Abdel-Hafeez Othman</investigator_full_name>
    <investigator_title>Associate Professor, OB-GYN department-principal investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
